Department of Veterans Affairs MEMORANDUM

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

Complete each item

1. Anticipated length of project: From _____ To______

2. Funding source:

3. Please indicate which of the following will be used at the VAMC:

a. Humans: no  yes  [If yes, please attach copy of IRB approval notification and IRB-approved consent form(s).]

b. Animals: no  yes  [If yes, please attach copy of approval from appropriate institution (VA or UK, depending on location of housing and use.)]

c. Biohazards (including Human tissue, samples, blood, hazardous chemicals, DNA, gene therapy, etc.): no  yes  [Please attach copy of VA approval]

d. Radioisotopes: no  yes  [Please attach copy of VA approval]

4. a. Identify VA space to be used:

b. Identify personnel working at the VA and indicate their status (Staff, Consultant, WOC):

5. a. Will outpatients be included? no  yes  (If so, Attachment B must be signed by Chief of Ambulatory Care).

b. Will inpatients be included? no  yes  (If so, Which bed service(s) will be

involved?) NOTE: Service Chief(s) for those services must sign Attachment B.

6.  Are there any additional tests, outpatient visits, hospitalization, etc. required for this study (other than those required for routine patient care)? If so, a memorandum must be attached indicating what tests (i.e. specific lab tests, x-rays, etc.), frequency of tests, and how their costs will be covered at the VA. This memorandum must show the concurrence of the appropriate Service Chief(s).

ATTACHMENT A


2. Subj: Research Proposal entitled,”

Response Code: Y = Yes, N = No, N/A = Not applicable

a. Clinical Laboratory: no  yes  (For information: Phil Flanary, Chief Medical Technologist, Ext 5936. Please flag pages containing clinical laboratory requirements)

b. Dietetics: no  yes 

c.  Infection Control: no  yes 

d. Pharmacy no  yes 

(NOTE, attached Investigational Drug Record (amended VA 10-9012) must be completed for each drug used (investigational drugs; combinations of drugs; unapproved use of an approved drug; ancillary “high-cost, commercially-available” drugs) and forwarded to Pharmacy (contact point: Tracy Hart) for their consideration. NOTE: Non-formulary drugs that are furnished on protocol by the sponsor will not be furnished by the VA when the study is closed and/or when the patient goes off study[1].

e. Nuclear Medicine: no  yes 

f. Nursing (beyond normal patients care): no  yes 

g. Radiology: no  yes 

h. SDTU: no  yes 

i. Operating Room: no  yes 

j. Procedure Room (e.g. recovery, cath lab, ICU's, etc.): no  yes 

k.  Other: (Please specify)

6.  If any additional resources are indicated in 5. above, the appropriate chief of service must indicate his/her concurrence on the attached sheet.

7. Does this study involve a new procedure or device? no  yes  (If yes, you must provide evidence that the individuals involved (including VA/UK staff and any outside consultants) have the appropriate clinical privileges)


3. Subj: Research Proposal entitled,”

Note: Any practitioner who will be performing or supervising patients care activities at the VA as part of this study must have VAMC-specific clinical privileges. In addition, if this study involves a new procedure or device, VA privileges specific to the device or procedure may be required. Please contact AA/Chief of Staff, or Betsy Budd, Medical Staff Coordinator, Ext 5125, if you have questions or need assistance.

Also, all individuals who will be involved in this study at the VA in other than a patient-care related manner (collecting data, reviewing charts, interviewing, working in a research lab, etc.) must have a VA appointment. Please contact Debie Hayse, Ext 4927, if you have questions or need assistance.

I certify that the information supplied above is correct and that all necessary privileges have been secured for all participants in the study.

______

Principal Investigator Date

ATTACHMENT A

Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Dennis D. Doherty, MD Chief, Medical Service Date

Mail code: 111-CDD

Location: A429 Cooper Drive

Ext: 4919 or 4211

ATTACHMENT B

Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Randal Schleenbaker, MD Chief, PM&RS Date

Mail code: 117-CDD

Location: A032A Cooper Drive

Ext: 4907

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Walter A. Divers, Jr., MD, MHSA Chief of Staff Date

Mail code: 11A-CDD

Location: A121 Cooper Drive

Ext: 4902

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Rayudu Polisetty, MD Chief, Radiology Service Date

Mail code: 114-CDD

Location: 110 Cooper Drive

Ext: 4263

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Wei-Jen Shih, MD Chief, Nuclear Medicine Service Date

Mail code: 115-CDD

Location: A155 Cooper Drive

Ext: 5928

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Bonnie Mitchell, MD Chief, Pathology and Laboratory Medicine Service Date

Mail code: 113-CDD

Location: B119 Cooper Drive

Ext: 4497 or 4923

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

James A. Flueck, MD ACOS/Ambulatory Care Date

Mail code: 11E-CDD

Location: B129Cooper Drive

Ext: 4905 or 4131

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Brian Kuehl Chief, Pharmacy Service Date

Mail code: 119-CDD

Location: A164 Cooper Drive

Ext: 5629

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY NURSING SERVICE MEMBER OF RESEARCH COMMITTEE IF ASSISTANCE (beyond normal Patients care) IS REQUIRED FROM NURSING PERSONNEL ON UNITS:

I have read and understood the proposal listed above and agree to the involvement of unit nursing personnel in this research.

______

Melinda Washburn Patient Care Services Date

Mail code: 003-CDD

Location: A131 Cooper Drive

Ext: 4922 or 3922

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Edward J. Kasarskis, MD, Ph.D. Chief, Neurology Service Date

Mail code: 127-CDD

Location: B302 Cooper Drive

Ext: 4219

ATTACHMENT B

Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Judy Rittenhouse Chief, Health Administration Date

Mail code: 136B-CDD

Location: (trailer)

Ext: 4877

ATTACHMENT B


Department of Veterans Affairs Memorandum

Date: November 19, 2008

From:

Subj: Research Proposal entitled,”

To: Research and Development Committee

TO BE SIGNED BY THE CHIEF OF EACH SERVICE INDICATED IN #5. ON COVER MEMORANDUM

I have read the proposal listed above and will provide the assistance/resources required.

______

Peter McKeown, MD Chief, Surgical Service Date

Mail code: 112-CDD

Location: B504-01-CDD

Ext: 4967

ATTACHMENT B

Revised: 5/9/07

[1] Any non-formulary drugs involved in patient care must go through the non-formulary approval process.

ATTACHMENT A